Founder · Executive · Researcher
Chris Gibson
CG
Current role not listed
Gibson co-founded Recursion and developed it from a university lab project into a public drug-discovery company. Its platform combines automated cell imaging, large biological datasets, and machine learning to search for new medicines. He served as CEO through January 2026 and left its board that June.
See something inaccurate or outdated?
Recursion